Structure-Activity Relationships of 9-Alkyladenine and Ribose-Modified Adenosine Derivatives at Rat A3 Adenosine Receptors
- 1 May 1995
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 38 (10) , 1720-1735
Abstract
Note: In lieu of an abstract, this is the article's first page.Keywords
This publication has 31 references indexed in Scilit:
- 2-Substitution of N6-Benzyladenosine-5'-uronamides Enhances Selectivity for A3 Adenosine ReceptorsJournal of Medicinal Chemistry, 1994
- Reversal of synaptic depression by serotonin at Aplysia sensory neuron synapses involves activation of adenylyl cyclase.Proceedings of the National Academy of Sciences, 1991
- N6,9-Disubstituted adenines: potent, selective antagonists at the A1 adenosine receptorJournal of Medicinal Chemistry, 1991
- [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.The Journal of Pharmacology and Experimental Therapeutics, 1989
- 2′,3′-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptorsEuropean Journal of Pharmacology, 1988
- 5′-Deoxy-5′-methylthioadenosine: A nucleoside which differentiates between adenosine receptor typesBiochemical Pharmacology, 1988
- N6‐Substituted 9‐methyladenines: A new class of adenosine receptor antagonistsFEBS Letters, 1987
- Ribose-modified adenosine analogs as adenosine receptor agonistsJournal of Medicinal Chemistry, 1986
- Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblastsBiochemical Pharmacology, 1981
- Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonistsCanadian Journal of Physiology and Pharmacology, 1980